Thrombolytics: How Clot-Busting Drugs Work, Types, Timing and Risks
Updated: 6 days ago
Written and medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026 · How we review
Quick Answer: What are thrombolytics?
Thrombolytics are emergency clot-busting drugs that break down fibrin, the protein holding a blood clot together, to restore blood flow. Doctors use them for stroke, heart attack and pulmonary embolism, given by IV or catheter, ideally within 4.5 hours of stroke symptoms starting. Bleeding is the main risk, so call emergency services at the first warning signs. [1]
What the research says
Earlier stroke treatment brings a bigger benefit. In 6,756 patients from nine randomized trials, 32.9% of people given alteplase within 3 hours had no significant disability at 3–6 months, compared with 23.1% of those not given the drug; the benefit shrank as delays grew, and symptomatic brain bleeding rose to 6.8% vs. 1.3%. (Emberson et al., Lancet, 2014) [2]
Clot-busting lowers death after pulmonary embolism, at a bleeding cost. Across 16 trials with 2,115 patients, death from any cause was 2.17% with thrombolytics vs. 3.89% with anticoagulants alone, but major bleeding was 9.24% vs. 3.42% and bleeding inside the skull 1.46% vs. 0.19%. (Chatterjee et al., JAMA, 2014) [3]
Tenecteplase holds up in stroke patients aged 80 and older. Pooling five trials of 1,307 very elderly patients, tenecteplase showed higher odds of good recovery at 90 days than alteplase (OR 1.35), with no significant difference in symptomatic brain bleeding (OR 1.00) or 90-day death (OR 0.84); the authors call the findings hypothesis-generating. (Zhang et al., Intern Emerg Med, 2026) [4]
Key takeaways
Thrombolytics dissolve clots that are already blocking blood flow; they are not the same as blood thinners.
They are used only in emergencies, in hospitals and ambulances.
Timing is critical: for stroke, treatment should start as soon as possible and within 4.5 hours.
Alteplase and tenecteplase are among the most common choices.
Bleeding is the main risk, and bleeding in the brain is the most serious complication.
What are thrombolytics?
Thrombolytics, also called fibrinolytic drugs, are clot-busting medicines that break up and dissolve blood clots blocking blood flow. [1]
When a clot cuts off blood supply, the heart, brain or another organ stops getting the oxygen it needs. Thrombolytic therapy clears the blockage quickly. This can save a life and prevent lasting damage. [1]
How do thrombolytics work?
Thrombolytics work as enzymes that start the breakdown of fibrin, the protein strands that bind a clot together. [1]
Once the fibrin breaks apart, the clot dissolves and blood can flow again. Doctors deliver the drug in one of two ways:
Through an IV in the arm, so it travels through the bloodstream.
Through a catheter placed right at the clot.
Both methods get the medicine where it needs to go fast. The sooner it starts working, the sooner normal blood flow returns to the blocked vessel. [1]
Thrombolytics break down fibrin so the clot dissolves and blood flow returns.
What conditions do thrombolytics treat?
Thrombolytics treat blood clots that have become dangerous or life-threatening. [1]
Condition | Where the clot is |
An artery supplying the brain | |
A coronary artery supplying the heart | |
An artery in the lungs | |
Venous thromboembolism | A vein, with risk of traveling to the lungs |
A deep vein, usually in the leg | |
Intracardiac thrombus | Inside the heart chambers |
Acute peripheral arterial occlusion | An artery in the leg |
Blocked central venous catheter | Inside a long-term IV line |
How soon should thrombolytics be given?
Thrombolytics should be given as soon as possible, usually within about half an hour of arriving at the hospital. [1]
Paramedics may even start the drug in the ambulance, before the patient reaches the hospital. [1]
Situation | Timing and approach |
Stroke | As soon as possible, within 4.5 hours of symptom onset, to help prevent long-term problems |
Heart attack | Less common; a procedure to open the artery (catheterization, often with a stent) is usually the most effective option |
Heart attack far from a specialized hospital | Thrombolytics may be given right away to protect the heart muscle |
Pulmonary embolism | As soon as possible after arrival |
What are the types of thrombolytic drugs?
Seven thrombolytic drugs are in use or under study, and each has its own strengths and drawbacks. [1]
Drug | Key features |
Alteplase (t-PA) | Often the top choice for stroke, pulmonary embolism and heart cases; rarely causes allergic reactions |
Tenecteplase | Works efficiently; a frequent choice in North America and Europe; smaller bleeding risk |
Reteplase | Works faster than other thrombolytics |
Streptokinase | The most used worldwide but not common in the US; cheaper, though many people react allergically; affects the whole body |
Urokinase | Used for leg-artery clots and blocked catheters; often chosen outside the US because it costs less |
Anistreplase | Targets all plasminogen, not only plasminogen bound to fibrin, so it acts throughout the body |
Prourokinase | Still being tested; must convert to urokinase to work |
Alteplase and tenecteplase are among the most widely used clot-busting drugs.
How are thrombolytics different from anticoagulants and antiplatelets?
Thrombolytics dissolve a clot that has already formed, while anticoagulants and antiplatelets help stop new clots from forming. [1]
Thrombolytics are emergency drugs. You will not find them at a pharmacy, but hospitals and ambulances keep them on hand. Anticoagulants, often called blood thinners, are medicines a provider prescribes to prevent dangerous clots. When anticoagulants succeed, thrombolytics are never needed. [1]
Drug group | What it does | When it is used | Examples |
Thrombolytics | Dissolve an existing clot | Emergencies, in hospital or ambulance | Alteplase, tenecteplase |
Anticoagulants | Slow the body's ability to form clots | To prevent dangerous clots | Heparin, warfarin |
Antiplatelets | Stop platelets from sticking together | To prevent another stroke or heart attack | Aspirin |
Thrombolytics break clots down; blood thinners help prevent them.
What are the benefits of thrombolytics?
Thrombolytics restore blood flow quickly, which limits the damage caused by a lack of oxygen. [1]
People who receive thrombolytics soon after a stroke have a better chance of a complete recovery than those who do not get the drug within that short window. [1]
What are the risks and side effects of thrombolytics?
Bleeding is the main risk of thrombolytics, and it can happen without warning. [1]
About one in four people who receive thrombolytics have minor bleeding. Serious or life-threatening bleeding is rarer. The most feared complication is bleeding in the brain, which can itself cause a stroke. Learn more about critical blood loss and emergency care. [1]
Bleeding risk is higher if you… |
Are an older adult |
Tend to bleed easily |
Recently had a stroke or surgery |
Take a blood thinner |
Have uncontrolled blood pressure |
Other possible complications include:
Clot fragments: a small piece of the broken clot can travel further into the body. A CT scan or echocardiogram can check for leftover pieces.
Allergic reactions: some people react to the drug.
Low blood pressure: the care team checks blood pressure closely during treatment. [1]
What does recovery after thrombolytic therapy look like?
Recovery after thrombolytic therapy depends on the condition that was treated. [1]
After a heart attack or stroke, a hospital stay of about a week is common. Many people then need rehabilitation to help the parts of the body affected by the event. For an example of stroke-related recovery, see our guide to Weber syndrome and stroke recovery. [1]
When should you call emergency services?
You should call emergency services (911 in the US) right away if you think you or someone near you is having a heart attack, stroke or pulmonary embolism. [1]
All three are emergencies. Calling an ambulance gives the best chance of survival, because treatment can begin before reaching the hospital. Contact a healthcare provider promptly if you think you may have deep vein thrombosis or venous thromboembolism. [1]
Conclusion
Thrombolytics are powerful emergency drugs that dissolve clots blocking blood flow to the brain, heart, lungs or limbs. They work best when given fast, ideally within 4.5 hours of a stroke and the sooner the better, and their main risk is bleeding. Knowing the warning signs of a heart attack and stroke, and calling emergency services immediately, is what makes timely treatment possible. [1]
Protect yourself and the people you love: share this guide with your family so everyone knows to act fast, and explore our related heart and brain health guides, such as microvascular ischemic disease and heart block. For a deeper clinical overview, see this thrombolytic therapy encyclopedia entry and this clinical review of thrombolytic therapy. [5][6]
FAQ
What are thrombolytics?
Thrombolytics are clot-busting drugs that break up and dissolve blood clots blocking blood flow. Doctors use them in emergencies such as stroke, heart attack and pulmonary embolism.
How fast must thrombolytics be given for a stroke?
Thrombolytics should be given as soon as possible after a stroke, within 4.5 hours for eligible people, to help prevent long-term problems. Hospitals usually aim to start treatment within about half an hour of arrival.
Is heparin a thrombolytic drug?
Heparin is not a thrombolytic drug; it is an anticoagulant that slows the body's ability to form clots. Heparin is given by IV or as an injection under the skin, and some forms can be used at home.
Is aspirin a thrombolytic drug?
Aspirin is not a thrombolytic drug; it is an antiplatelet that keeps platelets from sticking together to form a clot. Providers may recommend aspirin to help prevent another stroke or heart attack.
What is the most common thrombolytic drug?
Alteplase (t-PA) is often the top choice for stroke, pulmonary embolism and heart cases. Streptokinase is the most used worldwide because it costs less, though allergic reactions are common.
What are the side effects of thrombolytics?
Bleeding is the main side effect of thrombolytics, with about one in four people having minor bleeding. Rarer risks include serious bleeding in the brain, clot fragments traveling, allergic reactions and low blood pressure.
Can you buy thrombolytics at a pharmacy?
Thrombolytics are not sold at pharmacies. Hospitals and ambulances keep them on hand for emergency treatment of conditions such as heart attack and stroke.
How long is recovery after thrombolytic therapy?
Recovery after thrombolytic therapy depends on the condition treated, and a hospital stay of about a week is common after a heart attack or stroke. Rehabilitation may follow to help affected parts of the body.
How are thrombolytics given?
Thrombolytics are given through an IV in the arm so they travel through the bloodstream. In some cases, they are delivered through a thin tube placed right at the clot.
Which conditions are treated with thrombolytics?
Doctors use thrombolytics mainly for stroke caused by a clot, heart attack and serious blood clots in the lungs. They are given in a hospital, where the team can watch for bleeding.
Related Reading
Thrombolytic Therapy Procedure: Types, What to Expect, Risks, and Recovery explains how thrombolytic therapy is given and what recovery is like.
Heart Attack Symptoms and Treatment: A Complete Guide covers heart attack warning signs and emergency treatment.
Stroke: Symptoms, Causes, Diagnosis, and Treatment — A Complete Guide explains stroke symptoms and why fast treatment matters.
Deep Vein Thrombosis (DVT): Symptoms, Causes, Diagnosis & Treatment — Complete Guide explains how leg vein clots are diagnosed and treated.
References
Cleveland Clinic. Thrombolytics and Thrombolytic Therapy. Cleveland Clinic. Last updated June 12, 2022. https://my.clevelandclinic.org/health/treatments/23238-thrombolytics
Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929-1935. PMID 25106063. https://doi.org/10.1016/S0140-6736(14)60584-5
Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014;311(23):2414-2421. PMID 24938564. https://doi.org/10.1001/jama.2014.5990
Zhang K, Wang Q, Gong T, et al. Efficacy and safety analysis of tenecteplase vs. alteplase in very elderly patients with acute ischemic stroke: a systematic review and meta-analysis of randomized trials. Intern Emerg Med. 2026. Epub ahead of print. PMID 42704605. https://doi.org/10.1007/s11739-026-04517-5
MedlinePlus. Thrombolytic therapy. MedlinePlus Medical Encyclopedia. Last updated June 1, 2026. https://medlineplus.gov/ency/article/007089.htm
Baig MU, Patel P. Thrombolytic Therapy. StatPearls. Last updated July 5, 2026. https://www.ncbi.nlm.nih.gov/books/NBK557411/
Medical disclaimer
This article is for general educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of a qualified healthcare provider with any questions about a medical condition. If you think you are having a medical emergency, call your local emergency number immediately.
Comments